Source:http://linkedlifedata.com/resource/pubmed/id/17405908
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007634,
umls-concept:C0017262,
umls-concept:C0023688,
umls-concept:C0024348,
umls-concept:C0039194,
umls-concept:C0086418,
umls-concept:C0231204,
umls-concept:C0439859,
umls-concept:C0441712,
umls-concept:C0678214,
umls-concept:C0919524,
umls-concept:C1171362,
umls-concept:C1425775,
umls-concept:C1515670
|
pubmed:issue |
2
|
pubmed:dateCreated |
2007-7-3
|
pubmed:abstractText |
Recent evidence indicates that natural killer (NK) cells can negatively regulate T-cell responses, but the mechanisms behind this phenomenon as a consequence of NK-T-cell interactions are poorly understood. We studied the interaction between the NKG2D receptor and its ligands (NKG2DLs), and asked whether T cells expressed NKG2DLs in response to superantigen, alloantigen, or a specific antigenic peptide, and if this rendered them susceptible to NK lysis. As evaluated by FACS, the major histocompatibility complex (MHC) class I chain-related protein A (MICA) was the ligand expressed earlier on both CD4(+) and CD8(+) T cells in 90% of the donors tested, while UL16-binding protein-1 (ULBP)1, ULBP2, and ULBP3 were induced at later times in 55%-75% of the donors. By carboxyfluorescein diacetate succinimidyl ester (CFSE) labeling, we observed that NKG2DLs were expressed mainly on T cells that had gone through at least one division. Real-time reverse-transcription polymerase chain reaction confirmed the expression of all NKG2DLs, except ULBP4. In addition, T-cell activation stimulated phosphorylation of ataxia-telangiectasia mutated (ATM), a kinase required for NKG2DLs expression after DNA damage, and ATM/Rad3-related kinase (ATR) inhibitors blocked MICA induction on T cells with a mechanism involving NF-kappaB. Finally, we demonstrated that activated T cells became susceptible to autologous NK lysis via NKG2D/NKG2DLs interaction and granule exocytosis, suggesting that NK lysis of T lymphocytes via NKG2D may be an additional mechanism to limit T-cell responses.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/GPI-Linked Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class I,
http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides...,
http://linkedlifedata.com/resource/pubmed/chemical/Isoantigens,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/RNA,
http://linkedlifedata.com/resource/pubmed/chemical/ULBP2 protein, human
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
110
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
606-15
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:17405908-Autolysis,
pubmed-meshheading:17405908-CD4-Positive T-Lymphocytes,
pubmed-meshheading:17405908-CD8-Positive T-Lymphocytes,
pubmed-meshheading:17405908-Cell Survival,
pubmed-meshheading:17405908-Flow Cytometry,
pubmed-meshheading:17405908-GPI-Linked Proteins,
pubmed-meshheading:17405908-Gene Expression Regulation,
pubmed-meshheading:17405908-Histocompatibility Antigens Class I,
pubmed-meshheading:17405908-Humans,
pubmed-meshheading:17405908-Intercellular Signaling Peptides and Proteins,
pubmed-meshheading:17405908-Isoantigens,
pubmed-meshheading:17405908-Killer Cells, Natural,
pubmed-meshheading:17405908-Leukocytes, Mononuclear,
pubmed-meshheading:17405908-Lymphocyte Activation,
pubmed-meshheading:17405908-NF-kappa B,
pubmed-meshheading:17405908-Polymerase Chain Reaction,
pubmed-meshheading:17405908-RNA,
pubmed-meshheading:17405908-T-Lymphocytes
|
pubmed:year |
2007
|
pubmed:articleTitle |
Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis.
|
pubmed:affiliation |
Department of Experimental Medicine, Istituto Pasteur-Fondazione Cenci Bolognetti, University La Sapienza, Rome, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|